Coty has agreed to hand the Gucci Beauty license back to Kering, the luxury conglomerate that owns the Gucci brand, in a deal valued at roughly $400 million. The move marks a strategic shift for both companies, with Coty planning to use the proceeds to reduce its debt load.
Under the agreement, Coty will continue to operate Gucci Beauty through at least June 30, 2027, after which the license will transfer fully to Kering. This gives Kering time to prepare its own beauty operations while Coty maintains revenue from the business for several more years.
What Is a License-Back Deal?
This transaction is what the industry calls a “license back in-house” arrangement. Coty has been running Gucci Beauty under a licensing agreement, meaning it handled everything from product development to marketing and distribution, while paying royalties to Kering. The brand owner—Kering—set the strategic direction and collected a fee, but Coty kept most of the operating profit.
Now, Kering is buying back that license, effectively bringing beauty production and sales under its own roof. This is a common move for luxury brands that want more control over their image and product quality, especially in the high-margin beauty segment. For Coty, it means giving up a major revenue stream but gaining cash to strengthen its balance sheet.
Why Coty Is Selling
Coty has been working to reduce its debt for years, and this deal fits squarely into that plan. The company took on significant borrowing to fund acquisitions and growth initiatives, and higher interest rates have made that debt more expensive. By selling the Gucci license, Coty can pay down some of those obligations without needing to issue new shares or sell other assets.
The $400 million price tag is a notable sum, though it represents only a portion of Coty’s total debt, which stood at several billion dollars as of its last filing. Still, the move signals to investors that management is serious about improving the company’s financial health.
For context, other companies have taken similar steps to deleverage. For example, Onsemi recently sold two chip fabs to cut costs and sharpen its focus, a strategy that often appeals to investors looking for disciplined capital allocation.
What It Means for Investors
For Coty shareholders, the deal removes some uncertainty about the company’s debt burden. Paying down debt can lower interest expenses and improve earnings per share over time, all else being equal. However, losing the Gucci license also means losing a steady source of revenue and profit. Investors will want to watch how Coty plans to replace that income, perhaps through other brand partnerships or internal growth.
For Kering, bringing Gucci Beauty in-house gives it more control over a lucrative product category. Luxury beauty is a high-margin business, and owning the operations directly could boost profitability if managed well. But it also requires investment in manufacturing, supply chain, and marketing—areas where Coty had expertise. Kering will need to build or buy that capability, which could take time and money.
The broader luxury sector has been under pressure from slowing demand in key markets like China, but beauty has remained relatively resilient. This deal suggests Kering sees long-term value in owning its beauty business, even as it navigates a challenging environment.
Looking Ahead
The transition period through mid-2027 gives both sides time to adjust. Coty can continue to generate cash from Gucci Beauty while preparing for the handover. Kering can start building its beauty infrastructure, possibly through acquisitions or internal development.
Investors should also consider the competitive landscape. Other luxury houses, such as LVMH and Chanel, already operate their own beauty divisions, and Kering’s move brings it more in line with those peers. For Coty, the focus will be on whether it can find new growth drivers to offset the loss of a key license.
In the meantime, the $400 million will help Coty shore up its finances, a move that many analysts view as prudent. As always, the real test will be execution: Can Coty manage the transition smoothly, and can Kering make its in-house beauty venture a success?
